Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: DaiS who wrote (8567)	5/26/1998 9:36:00 PM
From: DR.TECH	Respond to of 23519

FDA-is suppose to promote public saftey...Taking a patients word that he won't take nitro is not good enough. If a person takes viagra and happens to have a heart attack the next day....they are unconscious and can not tell anybody of their use and the emergency people or ICU will administer a nitro drip. If the FDA finds this as the cause of death they will take this very serious and many things could happen and none will be good for viagra......Expect all analyst to zero in on -.15 for the 2nd qtr. Intl business will be great but won't carry good enough margins till 3rd qtr. This company's cost structure is geared for US business so we need uptick in US scripts for postive EPS. Unfortunitly, only C/R analyst has enough guts to see futher than a month ahead. Next week scripts should bounce but the following week will be the holiday week so only 4 days.Won't it be great...bounce in scripts,next day FDA approval(JUST WHAT THE SHORTS DONT WANT).